Abstract:The study investigated the inhibitory effect and mechanism of tectorigenin derivative(SGY) against herpes simplex virus type Ⅰ(HSV-1) by in vitro experiments. The cytotoxicity of SGY and positive drug acyclovir(ACV) on African green monkey kidney(Vero) cells and mouse microglia(BV-2) cells was detected by cell counting kit-8(CCK-8) method, and the maximum non-toxic concentration and median toxic concentration(TC_(50)) of the drugs were calculated. After Vero cells were infected with HSV-1, the virulence was determined by cytopathologic effects(CPE) to calculate viral titers. The inhibitory effect of the tested drugs on HSV-1-induced cytopathy in Vero cells was measured, and their modes of action were initially explored by virus adsorption, replication and inactivation. The effects of the drugs on viral load of BV-2 cells 24 h after HSV-1 infection and the Toll-like receptor(TLR) mRNA expression were detected by real-time fluorescence quantitative PCR(RT-qPCR). The maximum non-toxic concentrations of SGY against Vero and BV-2 cells were 382.804 μg·mL~(-1) and 251.78 μg·mL~(-1), respectively, and TC_(50) was 1 749.98 μg·mL~(-1) and 2 977.50 μg·mL~(-1), respectively. In Vero cell model, the half maximal inhibitory concentration(IC_(50)) of SGY against HSV-1 was 54.49 μg·mL~(-1), and the selection index(SI) was 32.12, with the mode of action of significantly inhibiting replication and directly inactivating HSV-1. RT-qPCR results showed that SGY markedly reduced the viral load in cells. The virus model group had significantly increased relative expression of TLR2, TLR3 and tumor necrosis factor receptor-associated factor 3(TRAF3) and reduced relative expression of TLR9 as compared with normal group, and after SGY intervention, the expression of TLR2, TLR3 and TRAF3 was decreased to different degrees and that of TLR9 was enhanced. The expression of inflammatory factors inducible nitric oxide synthase(iNOS), tumor necrosis factor-α(TNF-α), and interleukin-1β(IL-1β) was remarkably increased in virus model group as compared with that in normal group, and the levels of these inflammatory factors dropped after SGY intervention. In conclusion, SGY significantly inhibited and directly inactivated HSV-1 in vitro. In addition, it modulated the expression of TLR2, TLR3 and TLR9 related pathways, and suppressed the increase of inflammatory factor levels.

Notoginsenoside ST-4 inhibits virus penetration of herpes simplex virus in vitro.

Antiherpesvirus Activity in Vitro and Immunoregulative Effect of Ginsenoside Rg3

Ginsenoside Re And Notoginsenoside R-1: Immunologic Adjuvants With Low Haemolytic Effect

Guanidine Modifications Enhance the Anti-Herpes Simplex Virus Activity of (E,e)-4,6-bis(styryl)-pyrimidine Derivatives in Vitro and in Vivo.

Anti-inflammatory, Anti-Angiogenetic and Antiviral Activities of Dammarane-Type Triterpenoid Saponins from the Roots of Panax Notoginseng.

Inhibition of Herpes Simplex Virus Infection by Oligomeric Stilbenoids Through Ros Generation

New dammarane-type triterpenoid saponins from Panax notoginseng saponins

Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.

Possible Mode of Action of Antiherpetic Activities of a Proteoglycan Isolated from the Mycelia of Ganoderma Lucidum in Vitro.

In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-β-D-glucose from Phyllanthus emblica L. (Euphorbiaceae).

Pentagalloylglucose Blocks the Nuclear Transport and the Process of Nucleocapsid Egress to Inhibit HSV-1 Infection.

Activity investigation of pinostrobin towards herpes simplex virus-1 as determined by atomic force microscopy

[Anti-herpes simplex virus type Ⅰ of tectorigenin derivative and effect on Toll-like receptors in vitro]

A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: case study.

Inhibition of Herpes Simplex Virus Infection by a GLP Isolated from Mycelium of Ganoderma Lucidum

Antiviral Activities of Officinaloside C against Herpes Simplex Virus-1

Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro.

Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action

Antiviral Properties of R. Tanguticum Nanoparticles on Herpes Simplex Virus Type I in Vitro and in Vivo

Inhibition of Herpes Simplex Virus by Myricetin Through Targeting Viral Gd Protein and Cellular EGFR/PI3K/Akt Pathway

In vivo and in vitro antiviral activity of five Tibetan medicinal plant extracts against herpes simplex virus type 2 infection